ClinicalTrials.gov
public full text
Public Domain
A Study of LY3832479 (LY-CoV016) in Healthy Participants
The main purpose of this study is to learn more about the safety of LY3832479 and any side effects that might be associated with it. Blood tests will be done to measure how much LY3832479 is in the bloodstream and how long it takes the body to eliminate it. Participation could last up to 16 weeks and may include up to 10 visits to the study center.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3841136 in Healthy and Overweight Participants#876778
- A Safety Study of LY3372689 in Healthy Participants#1172415
- A Study of LY3463251 in Healthy Participants#906560
- A Study of LY3532226 in Healthy Participants#904852
- A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus#868322
Record · ID 1152266
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive